These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38353873)

  • 21. Challenges in the diagnosis of post kala-azar dermal leishmaniasis.
    Salotra P; Singh R
    Indian J Med Res; 2006 Mar; 123(3):295-310. PubMed ID: 16778312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.
    Singh RP; Picado A; Alam S; Hasker E; Singh SP; Ostyn B; Chappuis F; Sundar S; Boelaert M
    Trop Med Int Health; 2012 Nov; 17(11):1345-8. PubMed ID: 22882665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post Kala-Azar dermal leishmaniasis following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) for primary visceral leishmaniasis in Bihar, India.
    Burza S; Sinha PK; Mahajan R; Sanz MG; Lima MA; Mitra G; Verma N; Das P
    PLoS Negl Trop Dis; 2014; 8(1):e2611. PubMed ID: 24392171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An In-depth Proteomic Map of Leishmania donovani Isolate from Post Kala-azar Dermal Leishmaniasis (PKDL) Patient.
    Routaray CB; Kumar A; Sundar S; Sathe G; Pawar H; Pai K
    Acta Parasitol; 2022 Jun; 67(2):687-696. PubMed ID: 35020128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advanced case of PKDL due to delayed treatment: A rare case report.
    Topno RK; Rabi Das VN; Kumar M; Madhukar M; Pandey K; Verma N; Agrawal K; Lal CS; Siddiqui NA; Bimal S; Das P
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008052. PubMed ID: 32203500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantifying the Infectiousness of Post-Kala-Azar Dermal Leishmaniasis Toward Sand Flies.
    Mondal D; Bern C; Ghosh D; Rashid M; Molina R; Chowdhury R; Nath R; Ghosh P; Chapman LAC; Alim A; Bilbe G; Alvar J
    Clin Infect Dis; 2019 Jul; 69(2):251-258. PubMed ID: 30357373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinico-epidemiological analysis of Post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study.
    Ramesh V; Kaushal H; Mishra AK; Singh R; Salotra P
    BMC Public Health; 2015 Oct; 15():1092. PubMed ID: 26503551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic heterogeneity among visceral and post-Kala-Azar dermal leishmaniasis strains from eastern India.
    Dey A; Singh S
    Infect Genet Evol; 2007 Mar; 7(2):219-22. PubMed ID: 17027344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis.
    Bhandari V; Kulshrestha A; Deep DK; Stark O; Prajapati VK; Ramesh V; Sundar S; Schonian G; Dujardin JC; Salotra P
    PLoS Negl Trop Dis; 2012; 6(5):e1657. PubMed ID: 22629478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA polymorphism assay distinguishes isolates of Leishmania donovani that cause kala-azar from those that cause post-kala-azar dermal Leishmaniasis in humans.
    Sreenivas G; Raju BV; Singh R; Selvapandiyan A; Duncan R; Sarkar D; Nakhasi HL; Salotra P
    J Clin Microbiol; 2004 Apr; 42(4):1739-41. PubMed ID: 15071036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Tracking of the
    Moulik S; Sengupta S; Chatterjee M
    Front Cell Infect Microbiol; 2021; 11():623437. PubMed ID: 33692966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loop-mediated isothermal amplification methods for diagnosis of visceral leishmaniasis (
    Silva Nunes Bezerra G; Barbosa Júnior WL; Virgínia Batista Vieira A; Xavier AT; Sebastião Da Costa Lima Júnior M; Maria Xavier E; Silva EDD; Cintra Leal N; Medeiros ZM
    Expert Rev Mol Diagn; 2020 May; 20(5):455-465. PubMed ID: 32116067
    [No Abstract]   [Full Text] [Related]  

  • 33. Visceral Leishmaniasis IgG1 Rapid Monitoring of Cure vs. Relapse, and Potential for Diagnosis of Post Kala-Azar Dermal Leishmaniasis.
    Marlais T; Bhattacharyya T; Singh OP; Mertens P; Gilleman Q; Thunissen C; Hinckel BCB; Pearson C; Gardner BL; Airs S; de la Roche M; Hayes K; Hafezi H; Falconar AK; Eisa O; Saad A; Khanal B; Bhattarai NR; Rijal S; Boelaert M; El-Safi S; Sundar S; Miles MA
    Front Cell Infect Microbiol; 2018; 8():427. PubMed ID: 30619774
    [No Abstract]   [Full Text] [Related]  

  • 34. Detection of Leishmania donovani and L. tropica in Ethiopian wild rodents.
    Kassahun A; Sadlova J; Dvorak V; Kostalova T; Rohousova I; Frynta D; Aghova T; Yasur-Landau D; Lemma W; Hailu A; Baneth G; Warburg A; Volf P; Votypka J
    Acta Trop; 2015 May; 145():39-44. PubMed ID: 25700710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic accuracy of the Leishmania OligoC-TesT and NASBA-Oligochromatography for diagnosis of leishmaniasis in Sudan.
    Saad AA; Ahmed NG; Osman OS; Al-Basheer AA; Hamad A; Deborggraeve S; Büscher P; Schoone GJ; Schallig HD; Laurent T; Haleem A; Osman OF; Eltom AM; Elbashir MI; El-Safi S
    PLoS Negl Trop Dis; 2010 Aug; 4(8):e776. PubMed ID: 20689822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic typing reveals monomorphism between antimony sensitive and resistant Leishmania donovani isolates from visceral leishmaniasis or post kala-azar dermal leishmaniasis cases in India.
    Subba Raju BV; Gurumurthy S; Kuhls K; Bhandari V; Schnonian G; Salotra P
    Parasitol Res; 2012 Oct; 111(4):1559-68. PubMed ID: 22752721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of anti-gal enzyme-linked immunosorbent assay for the diagnosis of Indian post-kala-azar dermal leishmaniasis.
    Datta S; Ghosh M; Sarkar S; Saha B; Mukhopadhyay S
    Indian J Dermatol Venereol Leprol; 2019; 85(6):578-589. PubMed ID: 31397399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of cellular immunological responses in mono- and polymorphic clinical forms of post-kala-azar dermal leishmaniasis in India.
    Kaushal H; Bras-Gonçalves R; Avishek K; Kumar Deep D; Petitdidier E; Lemesre JL; Papierok G; Kumar S; Ramesh V; Salotra P
    Clin Exp Immunol; 2016 Jul; 185(1):50-60. PubMed ID: 26948150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Revisiting the role of the slit-skin smear in the diagnosis of Indian post-kala-azar dermal leishmaniasis.
    Bhargava A; Ramesh V; Verma S; Salotra P; Bala M
    Indian J Dermatol Venereol Leprol; 2018; 84(6):690-695. PubMed ID: 30058565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of SYBR green I based closed tube loop mediated isothermal amplification (LAMP) assay and simplified direct-blood-lysis (DBL)-LAMP assay for diagnosis of visceral leishmaniasis (VL).
    Dixit KK; Verma S; Singh OP; Singh D; Singh AP; Gupta R; Negi NS; Das P; Sundar S; Singh R; Salotra P
    PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006922. PubMed ID: 30439953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.